• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

Vitamin B in MCI: VITACOG results

February 8, 2012  

Future look: novel AD therapies in phase III testing

January 25, 2012  

ADAPT trial update: NSAIDs in AD

December 14, 2011  

No effect of cholesterol reduction on AD measures

November 9, 2011  

BP and Alzheimer’s disease: results inconclusive

September 21, 2011  

Beta-amyloid accumulation prior to cognitive impairment: longitudinal data

August 24, 2011  

AD progression associated with elevated coated platelet level

August 3, 2011  

Anxiety associated with cortical atrophy in AD

July 6, 2011  

Traumatic brain injury: no effect on AD phenotype

July 6, 2011  

Plasma clusterin a possible biomarker of AD severity

June 29, 2011  
Previous
3
4
5
6
7
Next

Browse by Topic

  • MS (418)
  • CLINICAL CASES IN MS (17)
  • BIOMARKERS IN MS (56)
  • EAN 2025 (2)
  • EPILEPSY (36)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A PATIENT WITH MRI LESIONS CONSISTENT WITH MS posted on June 27, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 26, 2025
  • EAN HIGHLIGHTS – TUESDAY, JUNE 24, 2025 posted on June 24, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions